BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10763150)

  • 21. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
    Pantel K; Schlimok G; Braun S; Kutter D; Lindemann F; Schaller G; Funke I; Izbicki JR; Riethmüller G
    J Natl Cancer Inst; 1993 Sep; 85(17):1419-24. PubMed ID: 7688814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells.
    Hjertner O; Qvigstad G; Hjorth-Hansen H; Seidel C; Woodliff J; Epstein J; Waage A; Sundan A; Börset M
    Br J Haematol; 2000 Jun; 109(4):815-22. PubMed ID: 10929035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
    Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
    Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
    Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of uPA, PAT-1, and uPAR in nipple aspirate fluid (NAF) with breast cancer.
    Qin W; Zhu W; Wagner-Mann C; Folk W; Sauter ER
    Cancer J; 2003; 9(4):293-301. PubMed ID: 12967140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
    Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
    J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin and enzyme-conjugated dextran polymers enhance u-PAR staining intensity of carcinoma cells in peripheral blood smears.
    Werther K; Normark M; Hansen BF; Nielsen HJ
    J Histochem Cytochem; 1999 Jul; 47(7):959-64. PubMed ID: 10375384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
    Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
    BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer.
    Tewes M; Kasimir-Bauer S; Welt A; Schuler M; Kimmig R; Aktas B
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):87-92. PubMed ID: 25108406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
    Borstnar S; Vrhovec I; Svetic B; Cufer T
    Clin Breast Cancer; 2002 Jun; 3(2):138-46. PubMed ID: 12123538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.
    Solomayer EF; Diel IJ; Wallwiener D; Bode S; Meyberg G; Sillem M; Gollan C; Kramer MD; Krainick U; Bastert G
    Br J Cancer; 1997; 76(6):812-8. PubMed ID: 9310251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma.
    Leinung S; Würl P; Weiss CL; Röder I; Schönfelder M
    Langenbecks Arch Surg; 2000 Aug; 385(5):337-43. PubMed ID: 11026705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy.
    Schmitt M; Harbeck N; Thomssen C; Wilhelm O; Magdolen V; Reuning U; Ulm K; Höfler H; Jänicke F; Graeff H
    Thromb Haemost; 1997 Jul; 78(1):285-96. PubMed ID: 9198168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
    Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunocytochemical Characterization of Disseminated Tumour Cells from Bone Marrow of Breast Cancer Patients.
    Andergassen U; Vogl A; Mumm JN; Kölbl AC; Hutter S; Rack B; Friese K; Jeschke U
    Anticancer Res; 2016 Jun; 36(6):3217-22. PubMed ID: 27272852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44
    Szczepanik A; Sierzega M; Drabik G; Pituch-Noworolska A; Kołodziejczyk P; Zembala M
    Gastric Cancer; 2019 Mar; 22(2):264-272. PubMed ID: 30056567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells.
    Lanza F; Castoldi GL; Castagnari B; Todd RF; Moretti S; Spisani S; Latorraca A; Focarile E; Roberti MG; Traniello S
    Br J Haematol; 1998 Oct; 103(1):110-23. PubMed ID: 9792297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.
    Fujita Y; Terashima M; Hoshino Y; Ohtani S; Kashimura S; Kanzaki N; Osuka F; Kogure M; Gotoh M
    Gastric Cancer; 2006; 9(4):308-14. PubMed ID: 17235634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness.
    Buø L; Meling GI; Karlsrud TS; Johansen HT; Aasen AO
    Hum Pathol; 1995 Oct; 26(10):1133-8. PubMed ID: 7557947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and characterisation of disseminated tumour cells in bone marrow of breast cancer patients by immunostaining of Her-2 and MUC-1 in combination with Thomsen-Friedenreich (CD176).
    Andergassen U; Kölbl AC; Zebisch M; Heublein S; Hutter S; Ilmer M; Schindlbeck C; Friese K; Jeschke U
    Histol Histopathol; 2014 Jul; 29(7):913-23. PubMed ID: 24399516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.